Special Issue "Urothelial Carcinoma: Clinical Diagnosis and Treatment"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 25 April 2023 | Viewed by 7427
Special Issue Editor
Interests: bladder cancer; radical cystectomty; radical nephroureterectomy; transurethral resection of bladder tumor; upper urinary tract urothelian carcinoma
Special Issue Information
Dear Colleagues,
Urothelial carcinoma (UC) represents the most common type of epithelial tumor diagnosed in Europe, North America, South America, and Asia. Although around 70–75% of newly diagnosed UC manifests as the non-muscle invasive bladder cancer, it can also involve the renal pelvis, ureter, and urethra. UC is a multifocal process, with tobacco smoking being the most relevant risk factor in developed countries. Patients with UC of the upper urinary tract have a 30% to 50% chance of developing cancer of the bladder, while patients with bladder cancer have a 2% to 3% chance of developing cancer of the upper urinary tract. Currently, UC represents a clinical and social challenge because of its incidence, post-treatment recurrence rate, and prognosis. In recent years, the poor diagnostic accuracy of available diagnostic tools such as urine cytology, white cystoscopy, and conventional imaging modalities have emphasized the urgent need for advancement in clinical guidance for UC. Moreover, novel treatment approaches, both medical and surgical, have significantly impacted the management of these patients. At the same time, the quality of life of these patients has gained growing interest. This Special Issue presents the up-to-date summaries related to the pathogenesis, diagnosis, prognostic assessment, and management of UC.
Prof. Dr. Massimiliano Creta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bladder cancer
- radical cystectomty
- radical nephroureterectomy
- transurethral resection of bladder tumor
- upper urinary tract urothelian carcinoma